Source: Google NewsPublished on 2021-02-16
Related Articles:
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 - GlobeNewswire February 18, 2021 Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 GlobeNewswire
- Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference - Yahoo Finance February 16, 2021 Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference Yahoo Finance
- Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 - StreetInsider.com February 18, 2021 Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 StreetInsider.com
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 - Yahoo Finance February 18, 2021 Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 Yahoo Finance
- Bayer doubles down on Parkinson’s? December 10, 2020 # # # # News today of two biotech companies merging did not cause much of a ripple in the media, but the wider implications of the move are rather significant for Parkinson’s. Today it was announced that Brain Neurotherapy Bio (BNB) is going to merge with Asklepios Biopharmaceutical (aka AskBio). BNB are currently clinically testing a GDNF gene therapy…
- Prevail lands on a Lilly pad December 15, 2020 # # # # 2020 has been a dreadful year for most of the world – burdened by the outbreak and consequences of COVID-19. Despite this, there has been a steady stream of biotech acquisitions related to Parkinson’s which have helped to keep morale high in the PD research community. In October alone, we saw the Portuguese pharmaceutical company Bial…
- Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis - GlobeNewswire December 15, 2020 Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis GlobeNewswire
- Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma's Acquisition of Arvelle Therapeutics - GlobeNewswire January 4, 2021 Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma's Acquisition of Arvelle Therapeutics GlobeNewswire
- Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 - GlobeNewswire February 9, 2021 Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 GlobeNewswire
- Monthly research review: February 2020 February 29, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
- 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
- Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Is it time for Parkinson’s home healthcare? March 18, 2020 Written in collaboration with Bud Rockhill who was a long-time Parkinson’s care partner to his mother At some point, your Parkinson’s may progress to the point that you need additional help at home. The timing and type of help depend on your medical condition, family situation, and financial resources. Still, it’s worth understanding the types of assistance that are available…
- Is it time for Parkinson’s home healthcare? March 18, 2020 Written in collaboration with Bud Rockhill who was a long-time Parkinson’s care partner to his mother At some point, your Parkinson’s may progress to the point that you need additional help at home. The timing and type of help depend on your medical condition, family situation, and financial resources. Still, it’s worth understanding the types of assistance that are available…
- Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma's Acquisition of Arvelle Therapeutics - BioSpace January 4, 2021 Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma's Acquisition of Arvelle Therapeutics BioSpace
- Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 - BioSpace February 9, 2021 Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 BioSpace
- AAN 2019 Plenary Session Highlights Research With Implications for Patient Care From Multiple Society Meetings May 9, 2019 The following article is part of conference coverage from the 2019 American Academy of Neurology Annual Meeting (AAN 2019) in Philadelphia, PA. Neurology Advisor’s staff will be reporting breaking news associated with research conducted by leading experts in neurology. Check back for the latest news from AAN 2019. PHILADELPHIA – A plenary session at the 2019 American Academy of Neurology…
- Monthly Research Review – December 2020 December 31, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- Making a strong case for GCase November 25, 2019 Novel therapies are increasing being developed to focus on specific subtypes of Parkinson’s. The hope is that if they work on one type of Parkinson’s, then maybe they will also work on others. Many of these new experimental treatments are focused on specific genetic subtypes of the condition, which involve having a specific genetic variation that increases one’s risk…